Cytocybernetics, a UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has been awarded $1.5 million by the National Institutes of Health (NIH) to develop an enhanced version of a device it created that integrates electronics with heart muscle cells to test how new drugs affect the heart’s electrical activity.